Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Myelodysplastic Syndromes

n(g),n(g')-dimethyl-l-arginine has been researched along with Myelodysplastic Syndromes in 1 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Štikarová, J1
Suttnar, J1
Pimková, K1
Chrastinová-Mášová, L1
Čermák, J1
Dyr, JE1

Other Studies

1 other study available for n(g),n(g')-dimethyl-l-arginine and Myelodysplastic Syndromes

ArticleYear
Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome.
    Journal of hematology & oncology, 2013, Aug-19, Volume: 6

    Topics: Adult; Arginine; Case-Control Studies; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes;

2013